Water‑Jet Surgery Helps Men With Painful Prostate Problems
Chronic prostatitis—also known as chronic pelvic pain syndrome—and an enlarged prostate (benign prostatic hyperplasia) often go hand in hand. For men suffering from both, the symptoms can be relentless: blocked urine flow, persistent discomfort, and months of unresolved pain.
The challenge? There’s no one-size-fits-all treatment. Doctors have struggled to find a way to address both issues simultaneously without risking side effects. But a groundbreaking pilot study may have found a solution—one that uses precision over power.
The Power of Precision: Aquablation Therapy
Researchers tested a robot-guided procedure called aquablation, which shreds excess prostate tissue using a highly controlled stream of water. Unlike traditional heat-based methods, this technique avoids thermal damage, targeting only the problematic tissue while preserving healthy areas.
The goal? Relief from urinary blockage and chronic pelvic pain—all in one procedure.
How the Study Worked
- Conducted at a single medical center
- Followed men with both chronic prostatitis and enlarged prostate
- Patients underwent aquablation and were tracked for changes in:
- Urinary symptoms
- Pain levels
- Overall quality of life
The Results? Encouraging.
Many participants reported fewer urinary difficulties and a significant reduction in pelvic pain. Early data suggests aquablation could be a dual-purpose solution, easing bladder pressure while addressing the root cause of chronic discomfort—without the burns or scarring common in other treatments.
Why This Matters for Patients
Imagine one surgery instead of multiple treatments. Less recovery time. Fewer side effects. A chance at lasting relief from two debilitating conditions.
The study’s authors stress that larger trials are needed—but for men trapped in the cycle of pain and obstruction, this could be a game-changer.
The Future of Prostate Care?
If further research confirms its benefits, aquablation might become the gold standard for men battling both chronic prostatitis and benign prostatic hyperplasia.
For now, hope is flowing in.
